Fresenius Kabi Limited: UK Public Sector Contracts Won & Awards
Large organisation·Companies House: Private Limited Company·Runcorn·Nationwide (UK)·Main market: Pharmaceutical products
Official UK PPONPZVH-4892-PJYY
i
How many tenders this supplier has won.
Tenders with at least one award to it. Award records are shown too, because one framework can carry many call-offs.
i
How many different public bodies have awarded to this supplier.
Buyers named on its awards, with duplicate names merged.
i
How much this supplier has won, by published values.
Sum of award values where it was the only winner, VAT excluded, framework ceilings left out.
Not turnover. Not every award publishes a value.
i
Approved provider lists and panels this supplier is on.
Procedures where the same published amount is awarded to three or more suppliers: the total of the list, repeated on every place. Each list counts once in the total.
A place on a list is not money won. The total belongs to the whole list.
i
Awards to this supplier in the last 12 months.
Award records dated in the last 12 months, against the two years before.
i
Contracts that finish in the next 18 months.
Published contracts with an end date in that window. No end date, not counted.
An end date does not confirm a new procurement.
i
In which regions this supplier wins work.
The region of each buyer it won from: the buyer’s office, placed by the official ONS postcode lookup. Each procedure counts once.
Where the buyer is based, not necessarily where the work was done; the tender page shows the published place of delivery.
Where they wini
In which categories this supplier wins.
Its awards by the category (CPV) of the lot won. An award to the whole procedure, with no lot named, counts once under the procedure’s main category.
i
In which categories this supplier wins.
Its awards by the category (CPV) of the lot won. An award to the whole procedure, with no lot named, counts once under the procedure’s main category.
212 awards (207 for a named lot, 98%, 5 for a whole procedure with no lot named; pending awards included) · top CPV classes, shares of all 212
3360 Pharmaceutical products125 awards · 59% · 124 lots + 1 whole-procedure3369 Various medicinal products36 awards · 17% · lots3314 Medical consumables12 awards · 6% · lots3319 Miscellaneous medical devices and products15 awards · 7% · 11 lots + 4 whole-procedure1588 Special nutritional products8 awards · 4% · lots3310 Medical equipments5 awards · 2% · lots3936 Sealing equipment5 awards · 2% · lots3316 Operating techniques3 awards · 1% · lotsi
How much this supplier has won, by published values.
Sum of award values where it was the only winner, VAT excluded, framework ceilings left out.
Not turnover. Not every award publishes a value.
i
What one of this supplier’s wins is usually worth.
Middle value of the same awards as the total above.
i
Does this supplier usually win above or below the buyer’s estimate.
Its own wins, estimate against award per lot, in its sector.
Based on 2 wins in its industry (CPV division 33). Small sample.
A past pattern, not a margin and not a price to bid.
Where their buyers arei
In which regions this supplier wins work.
The region of each buyer it won from: the buyer’s office, placed by the official ONS postcode lookup. Each procedure counts once.
Where the buyer is based, not necessarily where the work was done; the tender page shows the published place of delivery.
i
In which regions this supplier wins work.
The region of each buyer it won from: the buyer’s office, placed by the official ONS postcode lookup. Each procedure counts once.
Where the buyer is based, not necessarily where the work was done; the tender page shows the published place of delivery.
ITL1 region of the buyer office · known for 114 of 116 awarded procedures · each procedure counts once
Bidding recordi
Competitions this supplier is known to have bid in.
Lots on Procurement Act 2023 award notices naming it as a bidder, split into won and lost. The lot is the contest: three lots of a ten-lot notice is three wins and seven losses.
i
Competitions this supplier is known to have bid in.
Lots on Procurement Act 2023 award notices naming it as a bidder, split into won and lost. The lot is the contest: three lots of a ten-lot notice is three wins and seven losses.
Procurement Act 2023 award notices name every bidder · 11 notices name this supplier, covering 16 lots since 16 Jul 2025 · observed bids, not an estimate
i
Competitions this supplier is known to have bid in.
Lots on Procurement Act 2023 award notices naming it as a bidder, split into won and lost. The lot is the contest: three lots of a ten-lot notice is three wins and seven losses.
i
Frameworks and DPS this supplier got onto.
Lots appointed out of lots applied for. Kept apart from contract wins because almost every compliant bidder gets a place.
i
How many public bodies this supplier has bid to.
Buyers on notices that name it as a bidder, win or lose.
Bidder names come from Procurement Act 2023 award notices, which list every bidder (from 2025). Older notices name no bidders, so earlier contests do not appear here. Latest ten notices shown.
Who they sell toi
Which public bodies award work to this supplier.
Authorities named on its published awards, ranked by distinct procedures, duplicate names merged.
i
Which public bodies award work to this supplier.
Authorities named on its published awards, ranked by distinct procedures, duplicate names merged.
Authorities named on this supplier’s published awards · ranked by distinct procedures · a framework or DPS adds one award record per appointed supplier
i
What kinds of public bodies award work to this supplier.
Its award records by the authority’s published type, otherwise by its name. One framework can add many records.
NHS & health69%(146 awards)
146 of 212 awards are NHS & health (69%).Central government15%(32 awards)
32 of 212 awards are Central government (15%).Type not classified15%(32 awards)
32 of 212 awards are Type not classified (15%).Other public body1%(2 awards)
2 of 212 awards are Other public body (1%).
| Authority | Procedures | Share | Award records | Last activity |
|---|---|---|---|---|
| NHS England | 19 | 16.4% | 34 | 27 Aug 2026 |
| The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) | 10 | 8.6% | 29 | 9 Apr 2026 |
| Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts) | 10 | 8.6% | 10 | 30 Jun 2025 |
| The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") | 8 | 6.9% | 14 | 14 Sept 2023 |
| Department of Health & Social Care | 8 | 6.9% | 8 | 21 Feb 2023 |
| The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority") | 5 | 4.3% | 18 | 12 Dec 2025 |
| Procurement and Logistics Service | 5 | 4.3% | 11 | 28 Apr 2023 |
| NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) | 5 | 4.3% | 11 | 4 Jun 2026 |
Share = of the 116 procedures with an award naming this supplier. Last activity = award date, or notice publication when no award date was published.
Contracts endingi
Contracts that finish in the next 18 months.
Published contracts with an end date in that window. No end date, not counted.
An end date does not confirm a new procurement.
i
Contracts that finish in the next 18 months.
Published contracts with an end date in that window. No end date, not counted.
An end date does not confirm a new procurement.
Published end dates only · 195 of 206 awards carry one · not a retender forecast
| Contract | Ends | Published value |
|---|---|---|
| Lot 2 - CM/TNS/25/5725/02 | 31 Dec 2026 | £15,059,000 |
| Generic Anti-Infective Drugs | 31 Jan 2027 | £395,003 |
| Wave 15a - Hospital Only Products (DNW & DLN regions) | 31 Jan 2027 | £1 |
| Hospital Only Products | 31 Jan 2027 | £1 |
| Wave 15b - Hospital Only (Housekeeping) All regions | 31 Jan 2027 | £1 |
| Cancer Medicines (Group 2) | 31 Jan 2027 | £18,207,081 |
| Cancer Medicines | 31 Jan 2027 | £2,514,000 |
| NP49425 Generic and Biosimilar Transition Medicines | 28 Feb 2027 | £64,103,740 |
| Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept) | 28 Feb 2027 | £26,539,272 |
| Generic Drugs – Injections/Infusions 2 | 30 Jun 2027 | £5,841,104 |
Soonest 10 of 18.
Recent awards
Latest 30 of 206 award records naming this supplier
About this data
- Source. Official UK public procurement notices (Find a Tender), reused under the Open Government Licence v3.0. New notices arrive through the day; the figures are rebuilt nightly.
- One profile per supplier. Built from award and contract notices that name this supplier; different spellings and registration numbers of the same company are merged into this profile.
- Values are published values. The table mirrors what the notice published: framework ceilings and joint awards are labelled and never counted as this supplier's money, and † marks a value taken from the contract notice when the award published none. Only awards made to this supplier alone count towards its value, excluding VAT. It is not turnover.
- Regions on this page are where the work is delivered, not the supplier’s registered address.
- Contract end dates. Published on 195 of 206 awards; those feed “Contracts ending”.
- Every figure shows what it rests on. Not every notice publishes a bid count, a value or a delivery region, so each figure carries the number of records behind it, and one built on few records is marked as such. The on a figure explains it; the counting rules are in the methodology. Spotted something wrong? Tell us.